Evolution of the Average Target: Elekta AB

Evolution of the Target Price: Elekta AB

Changes in Analyst Recommendations: Elekta AB

c.YCdVXJV9s4OQ8Cym8zkW_UVew7mi4crKnmLo9t2gQF8.TW4gZdsu4cDTslj_m387hSs2sv3st46L2Civv7nCFgAuamw1piX25-i2bQ~6e7f1adda4c6c2624459d9ad3e79a5a3
09-09 JP Morgan cuts Coloplast, puts Ambu and Elekta on negative watch - BN FW
09-08 UBS reiterates sell on Elekta, sees continued risks FW
09-07 Elekta: Profitability finally improving; order book points to recovery Alphavalue
09-01 Barclays raises Elekta price target to 45.50 kronor (44.50), reiterates underweight - BN FW
08-28 Several raised price targets for Elekta after the earnings report FW
08-28 SB1 Markets raises target price for Elekta to 60 kronor (59), reiterates buy FW
08-28 Pareto Securities raises its target price for Elekta to 68 kronor (65), reiterates buy FW
08-27 Elekta: Profitability beat; healthy order intake growth; recovery ahead Alphavalue
08-26 Elekta expected to report SEK 318m in adjusted operating profit - FactSet FW
08-19 Nordea: Elekta on track for a profit recovery, reiterates buy FW
08-19 Handelsbanken Sees Historically Low Valuation in Elekta, Reiterates Buy FW
08-19 Nordea cuts Elekta price target to 63 kronor (65), reiterates buy FW
08-18 SEB cuts Elekta price target to 57 kronor (58), reiterates hold FW
08-13 SB1 upgrades Elekta to buy ahead of the Q1 report FW
08-13 SB1 Markets upgrades Elekta to buy (neutral), target price 59 kronor (57) FW
08-07 Pareto sees attractive valuation in Elekta ahead of Q1, reiterates buy FW
07-29 Goldman Sachs cuts Elekta target price to 50 kronor (55), reiterates sell - BN FW
07-17 Elekta: Caution on Chinese reforms + company specific execution Alphavalue
07-16 MedTech facing a three-front squeeze Alphavalue
07-08 Goldman Sachs cuts Elekta price target to 55 kronor (60), reiterates sell - BN FW
07-01 Pareto makes two changes to its Swedish monthly portfolio, adding Bilia and Nordrest FW
06-22 Deutsche Bank cuts Elekta price target to 52 kronor (60), reiterates hold FW
06-18 Affärsvärlden urges Elekta shareholders to be patient FW
06-18 SB1 Markets Reiterates Neutral Rating Following Elekta Capital Markets Day FW
06-18 Handelsbanken Reiterates Buy for Elekta, Citing Promising Evo Launch in U.S. FW

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+19.27%
+5.14%
+12.71%
+26.04%
+37.62%
+16.75%
+18.06%
+19.18%
+7.98%
+10.52%
Average +17.33%
Weighted average by Cap. +15.49%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
50.05SEK
Average target price
59.69SEK
Spread / Average Target
+19.27%
High Price Target
100.00SEK
Spread / Highest target
+99.80%
Low Price Target
41.00SEK
Spread / Lowest Target
-18.08%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!